在thalamocortical电路中的GABAergic动态:对缺席发作和过度抑制的洞察
Mohammad J Eslamizade1, Ali Dabbagh2, Fariba Karimzadeh3
1Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Neuroscience, Carleton University, Ottawa, Canada.
European journal of pharmacology
|January 16, 2026
概括
缺席发作涉及刺激/抑制不平衡,在甲状腺皮质回路中GABAergic系统功能障碍起着关键作用. 过度抑制,而不是过度兴奋,是主要的驱动因素,需要针对缺席进行向治疗.
科学领域:
- 神经科学是一个神经科学.
- 的研究研究.
- 神经药理学神经药理学
背景情况:
- 兴奋/抑制失衡理论解释了的机制.
- 该GABAergic系统,特别是在thalamocortical (TC) 电路中,至关重要.
- 缺席发作涉及这些电路中的特定功能障碍.
研究的目的:
- 审查GABAergic系统在正常条件和缺席发作期间在TC电路中的作用.
- 探索GABAergic神经元和突触活动对TC刺激性的影响.
- 检查GABA受体子单元和载体表达在没有发作时的病理生理学.
主要方法:
- 对实验和临床证据的文献综述.
- 在TC电路中分析GABAergic系统结构和功能.
- 研究GABA受体和转运体表达模式.
主要成果:
- 不同的GABAergic神经元/突触活动增加了TC和皮质神经元的刺激性,导致缺席的超振荡电路.
- 泰拉马斯和体感皮质的改变GABA受体子单元表达是关键.
- 较低的GABA输送体表达,特别是在星体细胞中,增加了突触GABA,促进了增强性抑制和T型通道激活.
结论:
- 由GABAergic系统变化驱动的过度抑制是缺席发作的主要病理生理学.
- 需要有针对性的药理干预和精准医学.
- 对TC相关疾病的进一步研究是有必要的.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Glutamate Antagonists
902
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
902
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.8K
Overview of Synapses
4.8K
A synapse is a specialized structure where two neurons connect, allowing them to pass an electrical or chemical signal to another neuron. It is the point of communication between neurons. The term "synapse" is derived from the Greek word "synapsis," which means "conjunction." The entire process of neural communication revolves around the synapse. When activated, a neuron releases chemicals known as neurotransmitters into the synapse. These neurotransmitters cross the synapse and bind to...
4.8K
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
831
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
831


